Conference
Phase II study of erlotinib (Tarceva, OSI774) in women with recurrent or metastatic endometrial cancer - NCICIND 148.
Authors
Oza AM; Elit L; Eisenhauer E; Hoskins PJ; Biagi J; Carey M; Dubuc-Lissoir J; Dundas G; Stuart G; Matthews S
Volume
9
Pagination
pp. 6094S-6094S
Publisher
AMER ASSOC CANCER RESEARCH
Publication Date
December 1, 2003
Name of conference
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Conference place
BOSTON, MASSACHUSETTS
Conference start date
November 17, 2003
Conference end date
November 21, 2003
Conference proceedings
CLINICAL CANCER RESEARCH
Issue
16
ISSN
1078-0432